| Control Cycle 1: Development of SFV Criteria – Main Group |
| Respondents |
nn50 |
TFP |
NN Min |
NN Max |
NN MW |
| RESPONDENT 1 |
0.00 |
680.30 |
774.00 |
907.00 |
849.47 |
| RESPONDENT 2 |
0.00 |
445.50 |
868.00 |
985.00 |
922.11 |
| RESPONDENT 3 |
241.00 |
5,651.50 |
758.00 |
1,086.00 |
919.67 |
| RESPONDENT 6 |
27.00 |
63,461.50 |
766.00 |
1,500.00 |
995.26 |
| RESPONDENT 7 |
0.00 |
469.00 |
969.00 |
1,047.00 |
1.011,31 |
| RESPONDENT 10 |
1.00 |
792.90 |
524.00 |
680.00 |
602.99 |
| RESPONDENT 11 |
136.00 |
6,399.40 |
688.00 |
1,063.00 |
905.43 |
| RESPONDENT 14 |
38.00 |
4,581.40 |
586.00 |
899.00 |
752.80 |
| RESPONDENT 15 |
127.00 |
7,888.10 |
719.00 |
1,024.00 |
898.13 |
| RESPONDENT 18 |
0.00 |
242.40 |
750.00 |
844.00 |
802.93 |
| RESPONDENT 19 |
0.00 |
296.80 |
711.00 |
821.00 |
750.92 |
| CB |
51.82 |
8,264.44 |
737.55 |
986.91 |
855.55 |
| Control Cycle 2: Development of SFV Criteria – Main Group |
| Respondents |
nn50 |
TFP |
NN Min |
NN Max |
NN MW |
| RESPONDENT 1 |
172.00 |
2,643.30 |
782.00 |
1,079.00 |
918.02 |
| RESPONDENT 2 |
28.00 |
1,476.60 |
907.00 |
1,086.00 |
1.001.27 |
| RESPONDENT 3 |
97.00 |
2,400.50 |
735.00 |
993.00 |
878.88 |
| RESPONDENT 6 |
9.00 |
894.60 |
719.00 |
938.00 |
783.01 |
| RESPONDENT 7 |
45.00 |
1,273.70 |
1,032.00 |
1,180.00 |
1,106.07 |
| RESPONDENT 10 |
0.00 |
955.20 |
571.00 |
727.00 |
643.57 |
| RESPONDENT 11 |
42.00 |
1,483.70 |
844.00 |
1,016.00 |
921.62 |
| RESPONDENT 14 |
141.00 |
16,231.70 |
688.00 |
1,126.00 |
957.32 |
| RESPONDENT 15 |
72.00 |
2,564.10 |
672.00 |
922.00 |
829.89 |
| RESPONDENT 18 |
1.00 |
544.10 |
750.00 |
852.00 |
803.88 |
| RESPONDENT 19 |
0.00 |
806,40 |
766.00 |
938.00 |
838.38 |
| CB |
55.18 |
2,843.08 |
769.64 |
987.00 |
880.17 |
| Control Cycle 3: Development of SFV Criteria – Main Group |
| Respondents |
nn50 |
TFP |
NN Min |
NN Max |
NN MW |
| RESPONDENT 1 |
0.00 |
1,335.40 |
696.00 |
868.00 |
788.26 |
| RESPONDENT 2 |
0.00 |
744.50 |
829.00 |
961.00 |
886.90 |
| RESPONDENT 3 |
10.00 |
1,739.90 |
782.00 |
946.00 |
877.23 |
| RESPONDENT 6 |
19.00 |
1,648.60 |
766.00 |
891.00 |
839.56 |
| RESPONDENT 7 |
33.00 |
1.041,10 |
993.00 |
1,141.00 |
1,084.08 |
| RESPONDENT 10 |
2.00 |
1,988.60 |
563.00 |
790.00 |
651.42 |
| RESPONDENT 11 |
95.00 |
3,094.70 |
743.00 |
961.00 |
878.63 |
| RESPONDENT 14 |
6.00 |
2,895.50 |
555.00 |
813.00 |
673.84 |
| RESPONDENT 15 |
151.00 |
4,459.10 |
782.00 |
1,032.00 |
919.72 |
| RESPONDENT 18 |
13.00 |
571.80 |
805.00 |
946.00 |
889.60 |
| RESPONDENT 19 |
0.00 |
581.50 |
641.00 |
735.00 |
698.21 |
| CB |
29.91 |
1,827.34 |
741.36 |
916.73 |
835.22 |
| Control Cycle 4: Development of SFV Criteria – Main Group |
| Respondents |
nn50 |
TFP |
NN Min |
NN Max |
NN MW |
| RESPONDENT 1 |
9.00 |
1,447.50 |
758.00 |
907.00 |
834.26 |
| RESPONDENT 2 |
0.00 |
724.80 |
750.00 |
876.00 |
814.94 |
| RESPONDENT 3 |
0.00 |
415.00 |
766.00 |
836.00 |
797.35 |
| RESPONDENT 6 |
6.00 |
3,614.40 |
680.00 |
883.00 |
774.34 |
| RESPONDENT 7 |
87.00 |
1,331.40 |
1,063.00 |
1,196.00 |
1,129.92 |
| RESPONDENT 10 |
3.00 |
533.50 |
516.00 |
688.00 |
598.10 |
| RESPONDENT 11 |
88.00 |
4,039.70 |
696.00 |
938.00 |
828.47 |
| RESPONDENT 14 |
94.00 |
8,365.40 |
672.00 |
1,024.00 |
869.36 |
| RESPONDENT 15 |
109.00 |
3,797.10 |
750.00 |
1,008.00 |
907.92 |
| RESPONDENT 18 |
1.00 |
959.00 |
868.00 |
977.00 |
932.13 |
| RESPONDENT 19 |
0.00 |
409.20 |
688.00 |
782.00 |
739.41 |
| CB |
36.09 |
2,330.64 |
746.09 |
919.55 |
838.75 |
| Conclusion: development of SFV criteria – Main Group |
|
|
|
| Respondents |
nn50 |
TFP |
NNmin |
NNMax |
NN MW |
| Control cycle 1 |
51,82 |
8,264.44 |
737.55 |
986.91 |
855.55 |
| Control cycle 2 |
55,18 |
2,843.08 |
769.64 |
987.00 |
880.17 |
| Control cycle 3 |
29.91 |
1,827.34 |
741.36 |
916.73 |
835.22 |
| Control cycle 4 |
36.09 |
2,330.64 |
746.09 |
919.55 |
838.75 |
| CB |
45.64 |
4,311.62 |
749.52 |
963.55 |
856.98 |
Total Nervous System Load (TFP) in subjects decreases with the use of the QHRS biopyramid. Total spectral energy (TFP) as a measure of influence on the vegetative and circulatory cardiac system. A total load of up to 6000 ms2 is treated as a "normal situation", and vice versa, TFP values close to zero are treated as "stiffness of the heart rate".
Subscribe to receive the latest updates on radiation protection and natural medicine.
No spam
Unsubscribe anytime
Share this knowledge
Help others learn more about natural space harmonization.